消息面上，微创机器人-B近期公告，集团旗下腔镜、骨科、血管介入核心产品的综合订单量累计突破230台。其中，核心产品图迈腔镜手术机器人（简称"图 迈"）在全球范围内的商业化订单累计超过160台，含今年新获订单近120台。上述综合订单中，集团旗下各产品共完成商业化装机150余台。 此外，微创机器人-B还公告，集团自主研发的支气管镜手术机器人独道®UniPathTM电子支气管镜手术导航系统（简称"独道"）正式获得国家药品监督管理 局批准。这是集团引领全球手术机器人领域技术与应用发展的里程碑式突破，也标志着国产手术机器人在微无创诊疗关键技术路径上实现系统性全覆盖。 来源：上海证券报·中国证券网 上证报中国证券网讯（记者 孔令仪）12月29日早盘，微创机器人-B一度涨超24%，最高报26.48港元/股。截至10时38分，微创机器人-B涨23.40%，报26.16港 元/股。 | | | | | ZO.UOU | | --- | --- | --- | --- | --- | | | | | न्नेंटर | 26.040 | | | | | 买7 | 26.020 | | | | | 录8 | 26.000 | | ...

西南证券发布研报称，12月24日，微创机器人-B(02252)发布自愿性公告，1）经初步统计公司手术机器 人产品综合订单累计突破230台，其中腔镜手术机器人全球商业化订单超160台；2）自主研发的支气管 镜手术机器人"独道"获批NMPA。 目前公司已获批手术机器人品种包括腔镜（图迈）、骨科（鸿鹄）、泛血管（R-ONE）、经皮穿刺 （Mona Lisa）和经支气管（独道），五大机器人管线均已获批NMPA。另外图迈、蜻蜓眼和鸿鹄均成 功获得海外注册证，海外布局加速落地。 西南证券主要观点如下： 全球商业化订单加速突破，国内海外双点开花 截至公告日，公司自研腔镜机器人"图迈"全球商业化订单超过160台，其中2025年新增订单约120台，彰 显强劲增长动能。国内端，图迈装机医院中三甲医院占比超过90%，百强医院占比达23%，高度医疗市 场认可度持续提升。海外端，公司依托集团在海外的成熟营销网络，加速亚洲、欧洲、非洲、大洋洲及 南美洲等40多个国家地区的海外布局，目前已在15国实现多台装机，是国产腔镜手术机器人出海的标志 性里程碑。 五大机器人版图已全部补齐，为现有品种最齐全的手术机器人公司 盈利预测：预计2025~2 ...

Core Insights - The company has achieved significant milestones in its robotic surgery product line, with a total of over 230 surgical robot orders, including more than 160 global commercial orders for its endoscopic surgical robot [1][2] - The company’s self-developed bronchoscopic surgical robot "Dudao" has received NMPA approval, further expanding its product offerings [1][3] Group 1: Order Growth and Market Presence - The company’s self-developed endoscopic robot "Tumi" has surpassed 160 global commercial orders, with approximately 120 new orders expected in 2025, indicating strong growth momentum [2] - In the domestic market, over 90% of the hospitals using Tumi are top-tier hospitals, with 23% being among the top 100 hospitals, reflecting a high level of market recognition [2] - The company is expanding its overseas presence, leveraging its established marketing network to penetrate over 40 countries across Asia, Europe, Africa, Oceania, and South America, with installations in 15 countries marking a significant milestone for domestic endoscopic surgical robots [2] Group 2: Product Line and Regulatory Approvals - The company has completed its portfolio of surgical robots, now offering five types: endoscopic (Tumi), orthopedic (Honghu), vascular (R-ONE), percutaneous (Mona Lisa), and bronchoscopic (Dudao), all of which have received NMPA approval [3] - Tumi, along with other products, has successfully obtained overseas registration certificates, accelerating the company’s international expansion [3] Group 3: Revenue Forecast - Revenue projections for the company are estimated to reach 500 million, 1.2 billion, and 1.8 billion yuan for the years 2025, 2026, and 2027 respectively, indicating a phase of rapid growth and impending volume increase [4]

Market Overview - The Hong Kong stock market opened high but closed lower, with the Hang Seng Index down 0.71% to 25,635.23 points and a total turnover of HKD 224.51 billion [1] - The Hang Seng Tech Index fell 0.3% to 5,483.01 points, while the Hang Seng China Enterprises Index decreased by 0.26% to 8,891.71 points [1] Consensus and Divergences - Huatai Securities noted two main consensus points: 1. The logic of the bulk commodity sector is solid, leading to a rapid revaluation 2. Weak recovery in domestic demand suggests a left-side allocation in the consumer sector [1] Blue Chip Performance - BYD Company (01211) led blue-chip stocks, rising 3.74% to HKD 97.1, contributing 20.66 points to the Hang Seng Index [2] - Other notable blue-chip performances included Geely Automobile (00175) up 3.43% and Industrial and Commercial Bank of China (01398) up 1.63% [2] Sector Highlights - The automotive sector saw most stocks rise, with NIO-SW (09866) up 4.89% and Xpeng Motors-W (09868) up 3.88% [3] - The robotics sector showed strong performance, with MicroPort Robotics-B (02252) surging 25.85% and UBTECH (09880) rising 9.13% [4] Individual Company News - UBTECH plans to acquire Fenglong Co. for HKD 1.665 billion, focusing on garden machinery and automotive components [5] - MicroPort Robotics reported over 230 cumulative orders for its surgical robots, with over 160 orders for its bronchoscopic surgical robot "Dudao" [5] Gold Sector Performance - Gold stocks generally retreated, with Zijin Mining International (02259) down 5.86% and Chifeng Jilong Gold Mining (06693) down 5.4% [5] - The gold market experienced volatility, with spot gold prices dropping below USD 4,450 per ounce [6] Power Sector Performance - Power stocks faced pressure, with Huaneng International (00902) down 6.48% and Datang International Power Generation (00991) down 4.7% [6] - The announcement of long-term electricity prices in Guangdong indicated a decline, with a 19.72 cents per kilowatt-hour drop [6] Notable Stock Movements - Junda Co. (02865) surged 21.65% following a strategic partnership announcement in the space energy sector [7] - Youjia Innovation (02431) rose 15.45% as the first batch of L3 autonomous vehicles began large-scale operation [8] - Goldwind Technology (02208) increased by 13.7% after the release of new listing standards for commercial rocket companies [9] - Jiantao Laminates (01888) rose 6.81% due to a price increase announcement amid rising copper prices [10] - MGM China (02282) fell 17.14% after a report indicated a significant increase in brand usage fees starting in 2026 [11]

Market Overview - The Hong Kong stock market experienced a decline, with the Hang Seng Index falling by 0.71% to close at 25,635.23 points, the Hang Seng Tech Index down by 0.3% at 5,483.01 points, and the China Enterprises Index decreasing by 0.26% to 8,891.71 points [1] - Major technology stocks mostly declined, with Alibaba down 1.85%, Tencent Holdings down 1.08%, and JD Group down 0.71%. However, Netease and Meituan saw gains of 1.41% and 0.97%, respectively [1] - Gold stocks fell significantly, with WanGuo Gold Group dropping over 6% and several others declining more than 5% [1] - Robotics stocks led the market, with MicroPort Robotics-B rising over 25% and UBTECH increasing by over 9% [1] - Automotive stocks performed well, with NIO up over 4% and both Xpeng Motors and BYD close to 4% [1] - Gaming stocks generally fell, with MGM China dropping over 17%, while Chinese brokerage stocks also saw declines, with China International Capital Corporation down over 2% [1] Company News - Kuaishou-W (01024.HK) repurchased 464,000 shares for approximately HKD 29.99 million at prices between HKD 64.05 and HKD 64.90 [2] - Bank of China (03988.HK) completed the issuance of HKD 50 billion in tier-2 capital bonds to supplement its tier-2 capital [2] - Weisheng Holdings (03393.HK) entered into a capital increase agreement with Boyu Capital, raising RMB 380 million for new shares [2] - Green Leaf Pharmaceutical (02186.HK) granted exclusive commercialization rights for three long-acting injectable antipsychotic products to Enhua in mainland China [3] - Hengrui Medicine (01276.HK) had its SHR-A1904 injection included in the list of breakthrough therapy products by the drug review center [4] - Tencent Holdings (00700.HK) repurchased 1.056 million shares for approximately HKD 636 million at prices between HKD 598 and HKD 604 [6] - COSCO Shipping Holdings (01919.HK) repurchased 1.96 million shares for approximately HKD 27.23 million at prices between HKD 13.82 and HKD 13.95 [7] - Xiaomi Group-W (01810.HK) repurchased 3.8 million shares for approximately HKD 149 million at prices between HKD 39.08 and HKD 39.26 [8] - Youzhiyou Biotechnology-B (02496.HK) received IND approval from NMPA for Y225 (Aimeisai monoclonal antibody injection) [9] - MicroPort Robotics-B (02252.HK) achieved a global commercialization milestone with over 100 installations of its surgical robots [10] - China Huadian Corporation (01071.HK) completed the construction and operation of two 660,000 kW ultra-supercritical units at the Huadian Longkou Phase IV project [11] - Energy International Investment (00353.HK) plans to issue a total of 1.035 billion shares at an approximately 18.33% discount, raising about HKD 254 million [12] Institutional Insights - CITIC Securities forecasts that the Hong Kong stock market may experience a second round of valuation recovery and performance revival in 2026, driven by internal and external economic factors [13] - Huatai Securities notes that the market is still in a left-side layout phase, with supply and demand pressures expected to persist towards the end of the year [14] - Qianhai Kaiyuan Fund's chief economist Yang Delong predicts that the Hong Kong stock market will regain upward momentum in 2026, driven by capital inflows and a potential long-term bull market [15]

每经AI快讯，12月29日，香港恒生指数收跌0.71%，恒生科技指数跌0.3%。黄金股下跌，万国黄金集团 跌超6%，中国黄金国际、紫金黄金国际、赤峰黄金、山东黄金均跌超5%。机器人概念股领涨，微创机 器人-B涨超25%，优必选涨超9%。 ...

Core Viewpoint - The humanoid robot sector in Hong Kong and A-shares is experiencing significant growth driven by favorable policies announced over the weekend, leading to a collective surge in related stocks [1][4]. Group 1: Stock Performance - A-share related concept stocks saw a collective rise, with notable performances including: - Buko Co., Ltd. reaching a limit-up of 20% at 121.66, an increase of 20.00% [2] - Chaojie Co., Ltd. up by 16.46% to 159.55 [2] - Wuzhi Electromechanical rising by 15.15% to 53.80 [2] - Other stocks like Tianqi Co., Ltd., Mould Technology, and Wuzhou Xinchun also hit the limit-up of 10% [2] - In the Hong Kong market, the robot concept stocks were also active, with MicroPort Robotics increasing by nearly 24% and UBTECH Robotics rising over 9% [2][3]. Group 2: Policy Developments - The establishment of the Humanoid Robot and Embodied Intelligence Standardization Technical Committee on December 26 marks a significant step in standardization within the humanoid robot sector, aimed at enhancing high-quality standards and promoting technology application [4]. Group 3: Industry Trends and Mergers - The capital activity in the robot sector has intensified, with multiple companies announcing mergers and joint ventures to strengthen core capabilities and seize market opportunities [5]. - Notable collaborations include: - Weichuang Electric and Zhejiang Rongtai forming a joint venture in Thailand for smart robot components [5] - Zhongding Co., Ltd. announcing a new joint venture focused on humanoid robot assembly [5]. - The trend of mergers and acquisitions is accelerating, with leading companies positioning themselves strategically within the market [5]. Group 4: Market Growth Potential - The humanoid robot industry is projected to enter a golden phase of large-scale development by 2025, with significant technological advancements observed throughout the year [7]. - The rapid technological breakthroughs are facilitating innovative business models, exemplified by the launch of the first open robot leasing platform in China [8]. - Long-term growth potential is substantial, with forecasts indicating the domestic market could approach 38 billion by 2030, with a compound annual growth rate exceeding 61% from 2024 to 2030 [8]. - Morgan Stanley anticipates the humanoid robot market could reach $5 trillion by 2050, with a deployment of 1 billion units [8][9].

Group 1 - The top ten gainers in the Hong Kong stock market include companies such as Shumeng Capital (08375.HK) with a gain of 71.88%, Easy Life Holdings (00223.HK) with 65.14%, and Guanglian Technology Holdings (02531.HK) with 62.82% [1][2] - Other notable gainers are Base Champion Group (08460.HK) with a 56.00% increase, Baide International (02668.HK) rising by 37.36%, and Qinhua Holdings (08082.HK) up by 28.57% [1][2] - Additional companies on the list include Yijun Group Holdings (02442.HK) with a 26.24% increase, MicroPort Scientific Corporation-B (02252.HK) gaining 25.47%, China Jinshi (01380.HK) up by 23.33%, and TEAMWAY International Group (01239.HK) with a 23.26% rise [1][2]

Market Overview - The Hong Kong stock market opened positively, with the Hang Seng Index rising by 0.43%, the National Enterprises Index increasing by 0.59%, and the Hang Seng Technology Index up by 0.88% [1][3]. Notable Stock Movements - BYD Company (01211) saw an increase of 3.53% - Geely Automobile (00175) rose by 3.31% - China Hongqiao (01378) increased by 3.28% - Li Auto (02015) gained 3.07% - In contrast, Xiaomi Group (01810) fell by 1.38%, JD Health (06618) decreased by 0.85%, and WuXi Biologics (02269) dropped by 0.31% [1][3]. Company Announcements - Longpan Technology (02465) opened 4.05% higher, announcing a change in its 2022 fundraising project plan. The annual production capacity for its new energy vehicle power and energy storage battery cathode material project was increased from 62,500 tons to 100,000 tons, a 60% increase from the original plan. The project investment is approximately 910 million RMB, with an internal rate of return of 12.59% and a payback period of 7.64 years. Completion is expected by May next year [1][3]. - MicroPort Scientific Corporation-B (02252) opened 6.7% higher after announcing that its self-developed bronchoscopic surgical robot, UniPath, received approval from the National Medical Products Administration [4]. - China Duty Free Group (01880) opened 6.78% higher, announcing that its wholly-owned subsidiary won the bid for the duty-free project at Beijing Capital International Airport, with a guaranteed operating fee of 480 million RMB for the first year and a sales commission rate of 5%. The contract is valid until February 10, 2034, for a maximum of 8 years [4]. Market Sentiment - Market sentiment was mixed, with U.S. stocks showing slight declines after a brief positive start. The S&P 500 index had reached a historical high before retreating. The U.S. dollar remained stable, and the yield on 10-year U.S. Treasuries fell to 4.13%. Gold prices continued to rise, while oil prices faced pressure [2][5]. - The mainland Chinese stock market showed a slight increase, with the Shanghai Composite Index rising by 0.1% and trading volume exceeding 2 trillion RMB [5]. - The Hong Kong market is expected to maintain a narrow trading range, fluctuating between 25,000 and 26,000 points [5].

港股机器人概念股走强，优必选涨超10%，微创机器人-B涨超10%、小鹏汽车-W涨超5%。 港股机器人概念股走强，优必选涨超10%，微创机器人-B涨超10%、小鹏汽车-W涨超5%。 ...